|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 10, 2019 ) Market Overview:
Needle-free blood drawing devices market is expected to grow at a CAGR of XX% to reach the market value of USD XXX million by 2026.
Needle-free blood drawing devices are used to draw the blood from the patient’s vein either by venepuncture or touch-enabled technology. In the case of venepuncture, the Intravenous Therapy (IV) needle is used to puncture the skin and then it is replaced with a plastic tube that becomes soft over some time.
Market Dynamics:
Increase in blood draws globally is one of the major factor having a positive impact on Needle-free blood drawing devices market, and is also expected to remain high over the forecast period. One of the major factor hindering the Needle-free blood drawing devices market is its high economic expenditure and unexplored.
Market Segmentation:
By Technology Type,
• Venepunture
• Touch based
By End users,
• Hospitals
• Research organizations
• Diagnostic centers
Geographical Analysis:
By Geography,
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Seventh Sense Biosystems
• Velano Vascular
• Tasso Inc.,
• Novartis International Ag
• Cerba Healthcare S.A.S.
View full report: https://www.datamintelligence.com/research-report/needle-free-blood-drawing-devices-market
Download free sample: https://www.datamintelligence.com/download-sample/needle-free-blood-drawing-devices-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
